Kestra Medical Technologies, Ltd. KMTS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.52% | -13.67% | -4.21% | -26.95% | 50.39% |
| Total Depreciation and Amortization | 14.58% | 17.25% | -16.43% | 17.01% | 10.46% |
| Total Amortization of Deferred Charges | -12.82% | -0.21% | 0.21% | -0.21% | 27.10% |
| Total Other Non-Cash Items | 30.93% | 10.32% | 3.14% | 258.70% | -88.99% |
| Change in Net Operating Assets | -252.18% | 133.03% | 197.61% | 111.89% | -234.51% |
| Cash from Operations | -72.52% | -1.93% | -0.13% | 30.19% | -9.22% |
| Capital Expenditure | 13.76% | 3.21% | -33.15% | 9.30% | -11.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.02% | -3,205.11% | -6,266.25% | 116.22% | 184.62% |
| Cash from Investing | 87.64% | -1,057.62% | -101.06% | 9.86% | -11.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 311.13% | -99.60% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -385.86% | -613.76% | -303.70% | 98.56% | 45.81% |
| Cash from Financing | 12,259.46% | -100.12% | 552,625.93% | 98.56% | -100.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.74% | -265.33% | 549.39% | 29.11% | -119.85% |